Yahoo Web Search

Search results

    • Immunocore (NASDAQ:IMCR) Rating Reiterated by Guggenheim

      ETF DAILY NEWS· 3 days ago

      Immunocore (NASDAQ:IMCR – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Guggenheim in a research report issued on Tuesday, Benzinga reports. Guggenheim ...